Beta Bionics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $16.83 |
Previous Close | $16.82 |
Day Range | $16.69-$16.96 |
52W Range | $8.80-$32.71 |
Market Cap | $749.5M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $110.2M |
Revenue Growth (YoY) | 56.6% |
Gross Profit (12 Mos) | $63M |
Diluted EPS | -$1.37 |
News
See moreYahoo Finance • 18 days ago
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Yahoo Finance • 24 days ago
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information
Yahoo Finance • 26 days ago
Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws
Yahoo Finance • 2 months ago
Beta Bionics projects $131M-$136M 2026 revenue and raises gross margin outlook to 57.5%-59.5%
About
CEO | Mr. Sean T. Saint PE |
CFO | Mr. Stephen H. Feider |
Address | 11 Hughes, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 420 |